Stock listing

NASDAQ:FDMT 4D Molecular Therapeutics, Inc. Stock

Home listing (NASDAQ) of 4D Molecular Therapeutics, Inc.

Follow 4D Molecular Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:FDMT

$10.23 USD -0.23 (-2.2%)

Close on Nov 20, 2026

Past year -1.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$10.11 – $10.94 USDNov 20, 2026
Volume
690,941 sharesNov 20, 2026
Market cap
$565.1M USDAt the close on Nov 20, 2026 · price × 55.24M shares outstanding
52-week range
$6.96 – $16.93 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$13.13M USDMedian day 897,223 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
4D Molecular Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:FDMT · Home$10.23 USD-0.23 (-2.2%)690,941$10.36$10.94$10.11$10.46Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FDMT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.23-0.23-2.2%$10.36$10.94$10.11690,941
$10.46-0.33-3.1%$10.77$10.99$10.30679,298
$10.79-0.50-4.4%$11.33$11.49$10.54813,812
$11.29-0.94-7.7%$12.25$12.34$11.22968,930
$12.23+0.115+0.9%$11.66$12.37$10.98813,801
$12.12-0.875-6.7%$12.59$12.86$12.05897,223
$12.99+0.53+4.3%$12.48$13.03$12.38837,170
$12.46-0.02-0.2%$12.43$12.76$12.151,075,502
$12.48+0.23+1.9%$12.42$12.71$12.15879,758
$12.25+1.00+8.9%$11.46$12.57$11.28993,257
$11.25-1.03-8.4%$12.11$12.11$11.161,598,595
$12.28+0.33+2.8%$12.36$12.42$11.55764,654
$11.95+0.58+5.1%$11.52$12.08$11.46740,402
$11.37-0.53-4.5%$11.88$12.06$11.16734,781
$11.90-0.88-6.9%$12.49$12.88$11.74683,476
$12.78-0.15-1.2%$13.00$13.46$12.57848,889
$12.93+0.97+8.1%$11.89$12.96$11.731,189,747
$11.96+0.93+8.4%$10.96$11.99$10.751,134,654
$11.03+0.23+2.1%$10.74$11.29$10.621,084,577
$10.80-1.05-8.9%$11.74$11.75$10.68996,140
$11.85-0.77-6.1%$12.60$13.12$11.681,354,686
$12.62-0.48-3.7%$13.12$13.45$12.612,019,208
$13.10+0.81+6.6%$12.29$13.39$12.29725,371
$12.29+0.15+1.2%$12.36$12.68$12.21855,679
$12.14-0.73-5.7%$12.84$12.84$12.00794,500
$12.87+0.67+5.5%$12.30$13.01$12.04787,600
$12.20-0.16-1.3%$12.18$12.58$11.99633,000
$12.36-0.64-4.9%$12.91$12.91$12.25991,700
$13.00-0.33-2.5%$13.30$13.47$12.86835,800
$13.33+0.63+5.0%$12.70$13.85$12.55867,900
$12.70+0.11+0.9%$12.42$12.74$12.12970,800
$12.59+0.03+0.2%$12.36$12.92$12.19603,600
$12.56-0.36-2.8%$12.64$13.02$12.301,170,900
$12.92-0.75-5.5%$13.86$13.86$12.612,110,300
$13.67-0.17-1.2%$14.12$14.14$13.601,036,900
$13.84-0.47-3.3%$14.23$14.58$13.80655,500
$14.31-0.18-1.2%$14.76$14.83$14.081,037,100
$14.49-0.07-0.5%$14.70$14.97$13.941,376,000
$14.56+0.09+0.6%$14.36$14.82$13.921,557,400
$14.47-0.24-1.6%$14.78$14.82$14.031,018,000
$14.71-0.29-1.9%$14.81$14.98$13.561,767,900
$15.00-0.88-5.5%$15.97$15.97$14.681,465,500
$15.88+0.64+4.2%$15.21$16.23$15.13936,600
$15.24+0.02+0.1%$15.57$15.70$14.68699,100
$15.22+0.54+3.7%$15.12$15.69$14.781,787,500
$14.68+0.92+6.7%$13.93$14.87$13.93930,600
$13.76+0.13+1.0%$13.65$14.20$13.55819,600
$13.63-0.13-0.9%$13.95$13.95$13.18552,000
$13.76+0.59+4.5%$13.64$14.19$13.43977,200
$13.17-0.32-2.4%$13.69$14.02$12.94481,100
$13.49-0.69-4.9%$13.88$14.02$13.40566,100
$14.18-0.45-3.1%$14.44$14.50$14.09493,800
$14.63-0.34-2.3%$14.57$15.29$14.13542,000
$14.97+0.27+1.8%$14.50$15.00$14.33420,600
$14.70-0.24-1.6%$14.94$14.94$14.28782,400
$14.94+0.59+4.1%$14.40$15.13$14.081,035,900
$14.35+0.24+1.7%$13.94$14.85$13.80708,000
$14.11-0.56-3.8%$14.49$14.60$13.671,404,200
$14.67-0.24-1.6%$14.92$15.00$14.201,101,300
$14.91-0.65-4.2%$15.44$15.77$14.82717,600
$15.56-0.16-1.0%$15.50$15.67$15.04717,900
$15.72+0.33+2.1%$15.69$16.34$15.42919,118
$15.39-0.44-2.8%$15.68$15.83$14.351,474,743
$15.83-0.27-1.7%$16.32$16.91$15.33918,700
$16.10-0.66-3.9%$16.50$16.71$15.631,630,800
Ticker
NASDAQ:FDMT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All 4D Molecular Therapeutics, Inc. news

Financings

  • Public offering of equity

    Nov 10, 2025

    Closed: US$93M raised · US$10.51 a share · Leerink Partners +3

    Dealers: Leerink Partners (co-lead), Evercore ISI (co-lead), Cantor (co-lead), RBC Capital Markets

    Use of proceeds: Fund planned operations into 2H 2028, including a planned 4D-150 Phase 3 trial in diabetic macular edema

    Announced Nov 6, 2025 · Closed Nov 10, 2025

  • Strategic investment of 4DMT equity

    Oct 13, 2025

    Tranche closed: US$7.5M raised

    Buyers: Cystic Fibrosis Foundation (up to $11 million in 4DMT equity in two tranches; first tranche of $7.5 million closed)

    Use of proceeds: Accelerate development of 4D-710 for cystic fibrosis: second dosing in Phase 1, advancement into Phase 2, and Phase 3 readiness

    Tranche closed Oct 13, 2025

Read by 6ix AI from the company's releases

Decks

4D Molecular Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 131 in all · newest Nov 13, 2026 · oldest 2020
Decks
24 decks · latest September 2026

Where 4D Molecular Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:FDMT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:FDMTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about 4D Molecular Therapeutics, Inc.